The fundraise may be undertaken through Qualified Institutional Placement (QIP), American Depository Receipts (ADR), Global Depository Receipts (GDR), preferential issue on a private placement basis, rights issue, or any other permissible mode, either singly or in combination and in one or more tranches.
“Raising of funds through one or more permissible mechanism as may be considered appropriate by the Board, by way of issuance of equity shares and/ or debt securities or non-convertible securities and/or other securities including share warrants and/ or any other equity linked securities including through Qualified Institutions Placement (QIP)/ issuance of Depository Receipts (ADR/GDR), preferential issue on a private placement basis, rights issue or such any other permissible mode or any combinations thereof, in one or more tranches, as may be decided by the Board, for an amount not exceeding ₹3,000 crore (Indian Rupees Three Thousand Crore Only) or its equivalent in any other currency, subject to approval of the members and/or such statutory/ regulatory approvals as may be required,” it said in a regulatory filing.
The proposed fundraise is subject to approval from the company’s members and any required statutory or regulatory authorities. The price or prices of the securities will be determined as permitted under applicable laws.
The board has also approved increasing Prime Focus’ authorised share capital to ₹100 crore from ₹85 crore. The authorised capital will comprise 100 crore equity shares of ₹1 each, compared with 85 crore equity shares of ₹1 each currently.
The company will consequently amend the capital clause of its Memorandum of Association, subject to shareholder and regulatory approvals. It said the board has also approved ancillary actions related to the proposed fundraise.
Shares of Prime Focus Ltd ended at ₹304.75, up by ₹12.75, or 4.37%, on the BSE.
First Published: Sept 4, 2026 8:42 PM IST
